C1368335||BRCA1-Associated Protein-1
C0597298||Isoform
C0025500||Mesothelioma Cells
C0013227||Drugs
C1528558||BRCA1
C0012899||DNA Repair
C1368335||BRCA1 associated protein1
C1368335||BRCA1 associated protein1
C0597611||tumor suppressor
C0007613||cellular processes
C1158770||transcriptional regulation
C1156197||chromatin modification
C1157996||deubiquitinating
C0147579||histone 2A
C0012899||DNA repair
C1368335||BRCA1 associated protein1
C0026882||mutations
C0812413||malignant pleural mesothelioma
C0812413||malignant pleural mesothelioma
C0597298||isoform
C1368335||of BAP1
C0017262||expression
C0812413||malignant pleural mesothelioma
C0017262||Expression
C1368335||BRCA1 associated protein1
C0442726||detected
C2733022||quantitative polymerase chain reaction
C0812413||malignant pleural mesothelioma
C0086610||mesothelium
C0007600||cell lines
C0475358||tumor
C1292533||nontumor samples
C0019646||Histone H2A
C1156207||ubiquitination
C0936012||analyzed
C0949466||Western blot
C0684295||acidic extraction
C2987130||core histones
C3893246||Subcellular
C1368335||BRCA1 associated protein1
C0597298||isoforms
C0332128||examined
C0079603||immunofluorescence
C0812413||malignant pleural mesothelioma
C0007620||cell survival
C0032405||poly(adenosine diphosphate-ribose) polymerase
C0032405||poly(adenosine diphosphate-ribose) polymerase
C0044602||phosphoinositide 3-kinase
C0044602||phosphoinositide 3-kinase
C1307407||mammalian target of rapamycin
C1307407||mammalian target of rapamycin
C0014432||inhibitors
C0936012||analyzed
C1515653||in vitro assays
C1720834||alternative splice isoform
C1368335||BRCA1 associated protein1
C1332380||BAP1
C0600499||catalytic domain
C0007634||Cells
C0040669||transfected
C1332380||BAP1
C1157996||deubiquitinating activity
C1368335||BRCA1 associated protein1
C0017262||expression
C1332380||BAP1
C1519595||transcript
C1292533||nontumor
C0812413||malignant pleural mesothelioma
C0085983||cell lines
C0017262||expressing
C1332380||BAP1
C2316164||olaparib
C1567710||PARP1
C0014432||inhibitor
C0596402||cytotoxicity
C2316164||olaparib
C3887704||treatment
C2984520||GDC0980
C0044602||phosphoinositide 3-kinase
C1307407||mammalian target of rapamycin
C0014432||inhibitor
C0013081||downregulation
C1528558||BRCA1
C0302523||observations
C1332380||BAP1
C3270705||regulate DNA damage response
C0017262||expression
C1332380||BAP1
C0521982||responsive
C0032405||poly(adenosine diphosphate-ribose) polymerase
C0044602||phosphoinositide 3-kinase
C1307407||mammalian target of rapamycin
C0014432||inhibitors